ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 386 filers reported holding ENCOMPASS HEALTH CORP in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $98,174 | -6.9% | 1,815 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $105,399 | -23.1% | 1,762 | +0.8% | 0.00% | -25.0% |
| Q2 2021 | $137,000 | 0.0% | 1,748 | +5.8% | 0.00% | -20.0% |
| Q4 2020 | $137,000 | +17.1% | 1,652 | -7.9% | 0.01% | -16.7% |
| Q3 2020 | $117,000 | +9.3% | 1,794 | +7.7% | 0.01% | -14.3% |
| Q1 2020 | $107,000 | -7.0% | 1,665 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $115,000 | +0.9% | 1,665 | -7.2% | 0.01% | -14.3% |
| Q3 2019 | $114,000 | 0.0% | 1,795 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $114,000 | +26.7% | 1,795 | +16.9% | 0.01% | +16.7% |
| Q1 2019 | $90,000 | -54.8% | 1,535 | -52.4% | 0.01% | -64.7% |
| Q4 2018 | $199,000 | +47.4% | 3,226 | +85.9% | 0.02% | +70.0% |
| Q3 2018 | $135,000 | +3.1% | 1,735 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $131,000 | +32.3% | 1,735 | +0.6% | 0.01% | +25.0% |
| Q1 2018 | $99,000 | +16.5% | 1,725 | 0.0% | 0.01% | +14.3% |
| Q4 2017 | $85,000 | – | 1,725 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |